Efficacy and safety of LY3298176 once weekly versus Insulin Glargine in patients with Type 2 Diabetes and increased cardiovascular risk.


Register Today!

Trial Information

Start DateAugust 2019
End Date2021
Trail Duration1 Year
Number of Visits26
Lead CRCAdam Pawluch
StatusOn-Going

For additional information on this trial contact:

Phone705-566-0005